Document Detail

Serum resistin: physiology, pathophysiology and implications for heart failure.
MedLine Citation:
PMID:  20550478     Owner:  NLM     Status:  MEDLINE    
Resistin, a 12.5-kDa polypeptide, has been associated with both insulin resistance and inflammation in animal models. Although initially discovered in the adipocytes, it has subsequently been found in other tissues. In humans, controversy still exists regarding the role of resistin but serum resistin concentration has been correlated with risk factors for coronary heart disease, renal dysfunction and outcomes among stroke patients. Both inflammation and insulin resistance are associated with the development of incident heart failure, with worse outcomes among those with prevalent cardiomyopathy. Therefore, it is interesting to note that recent literature suggests a significant relationship between serum resistin concentrations and heart failure. In this article, we discuss the physiology, pathophysiology, and the direct and indirect role of resistin in determining heart failure risk and worse outcomes among these patients. Some of the salient points reviewed include the possible association of resistin with hyperglycemia and substrate metabolism, inflammation through TNF-alpha and direct cardiac effects.
Vikas Bhalla; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Javed Butler
Related Documents :
11275938 - Serum complement activation in congestive heart failure.
24278308 - Maternal treatment with agonistic autoantibodies against type-1 angiotensin ii receptor...
17082748 - Vibrio vulnificus metalloprotease vvpe has no direct effect on iron-uptake from human h...
6347598 - Transient asystole associated with amphotericin b infusion.
14514548 - Deep pericardial stitch enables hemodynamically stable exposure of beating heart.
9141968 - Quantitative relation of electrocardiographic and angiocardiographic measures of risk i...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Biomarkers in medicine     Volume:  4     ISSN:  1752-0371     ISO Abbreviation:  Biomark Med     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-16     Completed Date:  2010-09-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101312535     Medline TA:  Biomark Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  445-52     Citation Subset:  IM    
Cardiology Division, Emory University Hospital, 1365 Clifton Road NE, Suite AT 430, Atlanta, GA 30322, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Heart Failure / blood,  etiology*
Inflammation / complications
Insulin Resistance
Resistin / blood*,  physiology
Risk Factors
Reg. No./Substance:
Erratum In:
Biomark Med.2010 Aug;4(4):643

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Residual platelet reactivity: predicting short- and long-term clinical outcome in patients undergoin...
Next Document:  The fatal attraction between pro-prion and filamin A: prion as a marker in human cancers.